Phonics Training Improves Reading in Children with Neurofibromatosis Type 1: A Prospective Intervention Trial - 23/09/16

Abstract |
Objective |
To examine the efficacy of a phonics-training program in children with neurofibromatosis type 1 (NF1) and reading difficulties.
Study design |
Thirty children (7-12 years of age) with NF1 completed a double-baseline, 24-week intervention trial. Literacy outcome measures were assessed at 4 time points: (1) at baseline; (2) after an 8-week no-treatment period; (3) immediately post-treatment; and (4) at follow-up 8 weeks post-treatment. Repeated-measures ANOVA were conducted to examine change over time for all outcome measures, and significant main effects were explored with planned comparisons. Predictors of treatment effects were examined by linear regressions.
Results |
Ninety percent of participants completed the intervention. Intervention-specific improvements were observed across a range of literacy outcomes, including reading accuracy (nonword reading, Cohen d = 1.10; regular-word reading, Cohen d = 0.32), letter-sound knowledge (Cohen d = 0.80), blending (Cohen d = 0.88), repetition of nonsense words (Cohen d = 0.94), phonemic decoding fluency (Cohen d = 0.55), and reading comprehension (Cohen d = 0.31). Improvements were maintained 8 weeks post-treatment. Age (P = .03) and working memory (P = .02) significantly influenced efficacy, with greatest improvements observed in older children with stronger verbal working memory capacity.
Conclusions |
Home-based, computerized reading intervention was effective in improving the reading and reading-related abilities of children with NF1 and reading difficulty.
Trial registration |
Australian and New Zealand Clinical Trials Registry: ACTRN12611000779976
Le texte complet de cet article est disponible en PDF.Keywords : neurofibromatosis type 1, reading deficit, phonics training, phonological awareness, intervention
Abbreviations : ADHD, CC2, FISIQ, NF1, SES, t1, t2, t3, t4, WISC-IV
Plan
| Supported by Children Tumor Foundation Young Investigator Award (2011-01-009 [to J.P.]). The authors declare no conflicts of interest. |
Vol 177
P. 219 - octobre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
